Global Ophthalmic Viscoelastic Devices (OVDs) Market Size By Type (Product Type I, Product Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Ophthalmic Viscoelastic Devices (OVDs) Market was valued at USD 1.2 billion in 2023 and is expected to reach USD 2.1 billion by 2031, growing at a CAGR of 7.3% during the forecast period from 2023 to 2031. OVDs play a crucial role in ophthalmic surgeries, particularly in cataract, glaucoma, and retinal procedures, by maintaining space, protecting ocular tissues, and enhancing surgical outcomes. The market's growth is primarily driven by the increasing prevalence of age-related ophthalmic disorders, advancements in surgical techniques, and a rising number of ophthalmic procedures globally.

Drivers:

1. Rising Incidence of Ophthalmic Disorders:

The global surge in conditions such as cataracts, glaucoma, and retinal detachment, especially among the aging population, is a primary factor driving demand for OVDs in surgical interventions.

2. Growth in Geriatric Population:

Aging individuals are more susceptible to vision-related disorders, leading to an increased number of cataract surgeries, which is significantly boosting the demand for OVDs.

3. Technological Advancements in Ophthalmic Surgery:

Innovation in surgical techniques, including micro-incision cataract surgery and femtosecond laser-assisted procedures, is driving the adoption of advanced viscoelastic materials tailored to meet these precise surgical requirements.

Restraints:

1. High Cost of Premium OVDs:

Advanced viscoelastic formulations often come at a high price, posing affordability issues, particularly in low- and middle-income countries, thereby limiting widespread adoption.

2. Regulatory and Reimbursement Challenges:

Stringent regulatory frameworks and inconsistent reimbursement policies for ophthalmic surgical devices in various regions may hinder market expansion.

Opportunity:

1. Growing Penetration in Emerging Markets:

Countries in Asia-Pacific and Latin America are witnessing rapid development in eye care infrastructure, presenting lucrative growth opportunities for OVD manufacturers.

2. Increasing Outpatient Surgeries:

The global trend toward minimally invasive procedures and outpatient settings for cataract and other eye surgeries is expected to propel the demand for efficient and easy-to-use OVDs.

Market by System Type Insights:

Based on system type, the Cohesive OVDs segment held the largest market share in 2023. Cohesive viscoelastics are widely used due to their excellent space-maintaining capability and ease of removal post-surgery. However, the Dispersive OVDs segment is projected to grow rapidly during the forecast period owing to their superior endothelial protection, making them crucial in complicated surgeries.

Market by End-Use Insights:

The Hospitals segment dominated the global OVDs market in 2023, accounting for over 45% of the revenue share. This dominance is due to the high volume of ophthalmic procedures performed in hospitals equipped with advanced surgical tools and specialized professionals. The Ophthalmic Clinics segment is anticipated to exhibit the fastest growth due to rising outpatient surgeries and growing investments in specialized eye care centers.

Market by Regional Insights:

North America led the global market in 2023, supported by a robust healthcare infrastructure, high awareness, and the presence of leading market players. However, Asia-Pacific is expected to record the fastest CAGR during the forecast period due to increasing healthcare spending, rapid urbanization, and expanding access to eye care services in countries such as India, China, and Japan.

Competitive Scenario:

Key players in the Global Ophthalmic Viscoelastic Devices Market include:

Johnson & Johnson Vision Care, Inc.

Alcon Inc.

Bausch & Lomb Incorporated

Carl Zeiss Meditec AG

Rayner Intraocular Lenses Ltd.

BVI Medical

CIMA Technology Inc.

Ophtechnics Unlimited

Carl Zeiss AG

Hyaltech Ltd.

These companies are focusing on product innovation, strategic collaborations, and geographic expansion to gain a competitive edge. Notable developments include Alcon’s introduction of new viscoelastic solutions tailored for laser cataract surgery in 2023, and Bausch & Lomb’s acquisition of an OVD technology company to strengthen its ophthalmic surgery portfolio.

Scope of Work – Global Ophthalmic Viscoelastic Devices (OVDs) Market

Report Metric Details

Market Size (2023) USD 1.2 Billion

Projected Market Size (2031) USD 2.1 Billion

CAGR (2023–2031) 7.3%

Market Segments System Type (Cohesive, Dispersive), End-Use

Growth Drivers Aging population, rise in ophthalmic surgeries

Opportunities Emerging markets, outpatient surgical trends

Key Market Developments:

2023: Alcon launched next-